This course is aimed at those working in the pharmaceutical
industry who need to be introduced to the language of economics
and economic evaluation. The course will provide an understanding
of the specific characteristics of health as an economic good, its
measurement, the indirect nature of the demand for health and the
imperfections of the market for health care. It explains how economists
evaluate the costs and benefits of health interventions, and how
decision makers in the health services and in the pharmaceutical
and medical technology industries use health economics. NICE will
be discussed and although based in the UK this will have relevance
to markets across Europe.
Nic Brereton
BresMed Health Solutions, Sheffield, UK
John Cairns
Professor of Health Economics
London School of Hygiene & Tropical Medicine
University of London, London, UK
Jim Furniss
Director of Market Access Solutions,
Bridgehead International Ltd, London, UK
Steve Parrott
Health Economist, Centre for Health Sciences, University of York,
York, UK
Click for course details with faculty biographies
